315 related articles for article (PubMed ID: 11087861)
1. Ubiquitin is part of the retrovirus budding machinery.
Patnaik A; Chau V; Wills JW
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13069-74. PubMed ID: 11087861
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.
Schubert U; Ott DE; Chertova EN; Welker R; Tessmer U; Princiotta MF; Bennink JR; Krausslich HG; Yewdell JW
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13057-62. PubMed ID: 11087859
[TBL] [Abstract][Full Text] [Related]
3. Retroviruses have differing requirements for proteasome function in the budding process.
Ott DE; Coren LV; Sowder RC; Adams J; Schubert U
J Virol; 2003 Mar; 77(6):3384-93. PubMed ID: 12610113
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.
Rocca A; Lamaze C; Subtil A; Dautry-Varsat A
Mol Biol Cell; 2001 May; 12(5):1293-301. PubMed ID: 11359922
[TBL] [Abstract][Full Text] [Related]
5. Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.
Patnaik A; Chau V; Li F; Montelaro RC; Wills JW
J Virol; 2002 Mar; 76(6):2641-7. PubMed ID: 11861830
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
[TBL] [Abstract][Full Text] [Related]
7. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
8. Equine infectious anemia virus and the ubiquitin-proteasome system.
Ott DE; Coren LV; Sowder RC; Adams J; Nagashima K; Schubert U
J Virol; 2002 Mar; 76(6):3038-44. PubMed ID: 11861870
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors: valuable new tools for cell biologists.
Lee DH; Goldberg AL
Trends Cell Biol; 1998 Oct; 8(10):397-403. PubMed ID: 9789328
[TBL] [Abstract][Full Text] [Related]
10. A role for ubiquitin ligase recruitment in retrovirus release.
Strack B; Calistri A; Accola MA; Palu G; Gottlinger HG
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13063-8. PubMed ID: 11087860
[TBL] [Abstract][Full Text] [Related]
11. Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.
Bowzard JB; Visalli RJ; Wilson CB; Loomis JS; Callahan EM; Courtney RJ; Wills JW
J Virol; 2000 Sep; 74(18):8692-9. PubMed ID: 10954570
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
13. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.
Jensen TJ; Loo MA; Pind S; Williams DB; Goldberg AL; Riordan JR
Cell; 1995 Oct; 83(1):129-35. PubMed ID: 7553864
[TBL] [Abstract][Full Text] [Related]
14. Impairment of the ubiquitin-proteasome system by protein aggregation.
Bence NF; Sampat RM; Kopito RR
Science; 2001 May; 292(5521):1552-5. PubMed ID: 11375494
[TBL] [Abstract][Full Text] [Related]
15. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
17. Late domain-dependent inhibition of equine infectious anemia virus budding.
Shehu-Xhilaga M; Ablan S; Demirov DG; Chen C; Montelaro RC; Freed EO
J Virol; 2004 Jan; 78(2):724-32. PubMed ID: 14694104
[TBL] [Abstract][Full Text] [Related]
18. Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting.
Medina G; Pincetic A; Ehrlich LS; Zhang Y; Tang Y; Leis J; Carter CA
Virology; 2008 Jul; 377(1):30-8. PubMed ID: 18555885
[TBL] [Abstract][Full Text] [Related]
19. An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
Wills JW; Cameron CE; Wilson CB; Xiang Y; Bennett RP; Leis J
J Virol; 1994 Oct; 68(10):6605-18. PubMed ID: 8083996
[TBL] [Abstract][Full Text] [Related]
20. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis.
Canu N; Barbato C; Ciotti MT; Serafino A; Dus L; Calissano P
J Neurosci; 2000 Jan; 20(2):589-99. PubMed ID: 10632588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]